147 related articles for article (PubMed ID: 30576883)
1. Documenting need for naloxone distribution in the Los Angeles County jail system.
Davidson PJ; Wagner KD; Tokar PL; Scholar S
Addict Behav; 2019 May; 92():20-23. PubMed ID: 30576883
[TBL] [Abstract][Full Text] [Related]
2. Overdose prevention training with naloxone distribution in a prison in Oslo, Norway: a preliminary study.
Petterson AG; Madah-Amiri D
Harm Reduct J; 2017 Nov; 14(1):74. PubMed ID: 29162122
[TBL] [Abstract][Full Text] [Related]
3. Characterizing and combating the opioid epidemic in the Los Angeles County jail system.
Tran NT; Muradian IK; Qureshi N; Singh J; Henderson SO
J Subst Use Addict Treat; 2023 Apr; 147():208984. PubMed ID: 36841073
[TBL] [Abstract][Full Text] [Related]
4. Overdose Education and Naloxone Distribution in the San Francisco County Jail.
Wenger LD; Showalter D; Lambdin B; Leiva D; Wheeler E; Davidson PJ; Coffin PO; Binswanger IA; Kral AH
J Correct Health Care; 2019 Oct; 25(4):394-404. PubMed ID: 31672075
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
Curtis M; Dietze P; Aitken C; Kirwan A; Kinner SA; Butler T; Stoové M
Harm Reduct J; 2018 Sep; 15(1):48. PubMed ID: 30241532
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
Parmar MK; Strang J; Choo L; Meade AM; Bird SM
Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Skåne County, Sweden.
Troberg K; Isendahl P; Blomé MA; Dahlman D; Håkansson A
BMC Psychiatry; 2020 Feb; 20(1):49. PubMed ID: 32028921
[TBL] [Abstract][Full Text] [Related]
8. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
[TBL] [Abstract][Full Text] [Related]
9. Preventing death among the recently incarcerated: an argument for naloxone prescription before release.
Wakeman SE; Bowman SE; McKenzie M; Jeronimo A; Rich JD
J Addict Dis; 2009; 28(2):124-9. PubMed ID: 19340674
[TBL] [Abstract][Full Text] [Related]
10. Naloxone use among overdose prevention trainees in New York City: A longitudinal cohort study.
Siegler A; Huxley-Reicher Z; Maldjian L; Jordan R; Oliver C; Jakubowski A; Kunins HV
Drug Alcohol Depend; 2017 Oct; 179():124-130. PubMed ID: 28772172
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal disease in Los Angeles County, California, and among men in the county jails.
Tappero JW; Reporter R; Wenger JD; Ward BA; Reeves MW; Missbach TS; Plikaytis BD; Mascola L; Schuchat A
N Engl J Med; 1996 Sep; 335(12):833-40. PubMed ID: 8778600
[TBL] [Abstract][Full Text] [Related]
12. Witnessed overdoses and naloxone use among visitors to Rikers Island jails trained in overdose rescue.
Huxley-Reicher Z; Maldjian L; Winkelstein E; Siegler A; Paone D; Tuazon E; Nolan ML; Jordan A; MacDonald R; Kunins HV
Addict Behav; 2018 Nov; 86():73-78. PubMed ID: 29175025
[TBL] [Abstract][Full Text] [Related]
13. Overdose prevention for prisoners in New York: a novel program and collaboration.
Zucker H; Annucci AJ; Stancliff S; Catania H
Harm Reduct J; 2015 Nov; 12():51. PubMed ID: 26541987
[TBL] [Abstract][Full Text] [Related]
14. Methods for delivering the UK's multi-centre prison-based naloxone-on-release pilot randomised trial (N-ALIVE): Europe's largest prison-based randomised controlled trial.
Meade AM; Bird SM; Strang J; Pepple T; Nichols LL; Mascarenhas M; Choo L; Parmar MKB
Drug Alcohol Rev; 2018 May; 37(4):487-498. PubMed ID: 28940805
[TBL] [Abstract][Full Text] [Related]
15. Criminal justice continuum for opioid users at risk of overdose.
Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
[TBL] [Abstract][Full Text] [Related]
16. Use of harm reduction strategies by individuals with a history of incarceration: A short report using baseline data collected from the STAMINA clinical trial.
Victor G; Ray B; Watson DP
J Subst Use Addict Treat; 2024 Jul; 162():209376. PubMed ID: 38641053
[TBL] [Abstract][Full Text] [Related]
17. Overdose Education and Naloxone Rescue Kits for Family Members of Individuals Who Use Opioids: Characteristics, Motivations, and Naloxone Use.
Bagley SM; Peterson J; Cheng DM; Jose C; Quinn E; O'Connor PG; Walley AY
Subst Abus; 2015; 36(2):149-54. PubMed ID: 25564892
[TBL] [Abstract][Full Text] [Related]
18. Extended-release naltrexone for opioid use disorder started during or following incarceration.
Lincoln T; Johnson BD; McCarthy P; Alexander E
J Subst Abuse Treat; 2018 Feb; 85():97-100. PubMed ID: 28479011
[TBL] [Abstract][Full Text] [Related]
19. Opioid overdose prevention training with naloxone, an adjunct to basic life support training for first-year medical students.
Berland N; Fox A; Tofighi B; Hanley K
Subst Abus; 2017; 38(2):123-128. PubMed ID: 28027016
[TBL] [Abstract][Full Text] [Related]
20. Changes in overdose knowledge and attitudes in an incarcerated sample of people living with HIV.
Reed M; Siegler A; Tabb LP; Momplaisir F; Krevitz D; Lankenau S
Int J Prison Health; 2021 Jun; AHEAD-OF-PRINT(AHEAD-OF-PRINT):. PubMed ID: 34120416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
